Donate

Blog

Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers

Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers

The law firm Hagens Berman has filed a complaint against Eli Lilly, Novo Nordisk, and Sanofi, the ‘big three’ pharmaceutical companies that hold a near-monopoly on the insulin market. People living with type 1 diabetes will be the plaintiffs in this class action lawsuit, which alleges that Eli Lilly, Novo Nordisk and Sanofi have unjustly inflated their prices. Read more

Supporting Refugees with type 1 diabetes in Germany

Supporting Refugees with type 1 diabetes in Germany

When refugees arrive in Germany and apply for asylum, the registration office and the doctors of Berlin’s refugee health department are the first people they meet. Oftentimes it is their first opportunity to see a health care professional in weeks or even months. During the past two years our health care system here in Germany has been overwhelmed by the large amount of immigrants coming to Europe. Many refugees got sick on their long and exhausting trip... Read more

T1International Year in Review: 2016

T1International Year in Review: 2016

What did T1International achieve in 2016? Lots! We raised funds to get insulin to Syrians in need, we carried out our Insulin & Supply survey to show how unaffordable type 1 diabetes really is, we launched the Type 1 Access Charter as well as the Advocacy toolkit, and so much more! Read more

Diabetes in Russia

Diabetes in Russia

Last February, I had the opportunity to leave my rural Cheshire home for a week to travel to Moscow. While there, I met with 3 women with diabetes. We shared stories and compared experiences, and my eyes were opened to the vastly different challenges that they face. Read more

Eli Lilly and Novo Nordisk: More Empty Promises

Eli Lilly and Novo Nordisk: More Empty Promises

Outrage at soaring insulin prices in the USA has been increasing. More patients and families are speaking out against unaffordable costs for life-saving medication than ever before. In response, two of the 'Big Three' insulin makers (who control over 90% of the insulin market) have recently made moves to combat this anger. Read more

Pharmadness: Your Chance to be a Pharma Company CEO

Pharmadness: Your Chance to be a Pharma Company CEO

Last month the Missing Medicines campaign, of which T1International is proudly a member, launched a new interactive game to illustrate the problems with the global research and development model. This experience is something that everyone should a few minutes to try. Read more

Ghana World Diabetes Day Camp

Ghana World Diabetes Day Camp

It was a very wonderful and emotional moment as we listened to the stories and life experiences that were shared. The experiences shared had a common theme about them. All those who shared their experiences stated the challenge of access to insulin and diabetes supplies. Read more

The Politics of Diabetes in Nigeria

The Politics of Diabetes in Nigeria

Support of people with diabetes and other non-communicable diseases from politicians is a common trend across the developed countries, and this has propelled them to advocate, create legislation and make policies for the education, prevention, diagnosing and management of diabetes in their respective countries. This is not the case in less-developed countries around the world... Read more

T1International Statement on ADA Insulin Price Petition

T1International Statement on ADA Insulin Price Petition

It is fantastic to see a large diabetes organization speaking out in this way. However, we feel that the ADA’s language around the call for price transparency does not go far enough. Read more

Sign the Type 1 Diabetes Access Charter

Sign the Type 1 Diabetes Access Charter

T1International is advocating for insulin and other vital diabetes supplies to be made available for everyone with diabetes through their Type 1 Diabetes Access Charter. Read more